Procedure for Risk Management in Stability Testing According to ICH Q9

1) Purpose

This SOP outlines the procedures for implementing risk management principles based on the ICH Q9 guidelines for stability testing. The goal is to identify, assess, and control risks that may impact the stability testing of drug products, ensuring consistent quality and regulatory compliance.

2) Scope

This SOP applies to all stability testing activities conducted within the organization. It is relevant to personnel involved in risk management, stability testing, quality assurance, and regulatory affairs.

3) Responsibilities

Risk Management Team: Responsible for identifying, assessing, and controlling risks associated with stability testing.
Stability Study Team: Responsible for implementing risk management strategies during stability testing.
Quality Assurance Team: Responsible for verifying that risk management procedures are followed.

4) Procedure

4.1 Risk Identification

4.1.1 Identify potential risks that may affect stability testing, such as environmental conditions, equipment failures, or

“Unveiling the Secret of Drug Stability: Exploring Chemical Kinetics to Ensure Long-lasting Effectiveness and Safety”

4.1.2 Document all identified risks using a risk assessment form.

4.2 Risk Assessment

4.2.1 Assess the likelihood and impact of each identified risk using a risk matrix.

4.2.2 Assign a risk level (low, medium, high) based on the assessment.

4.3 Risk Control

4.3.1 Develop strategies to mitigate or control high-risk areas.

4.3.2 Implement risk control measures and